TransMedics Group, Inc.

NASDAQ:TMDX

165.98 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016
Operating Activities:
Net Income -25.028-36.231-44.215-28.748-33.547-23.756-20.823-24.065
Depreciation & Amortization 8.2773.4781.8171.5771.2220.7690.630.426
Deferred Income Tax -1.6602.284-0.4310.3361.009-0.3160.292
Stock Based Compensation 19.79110.3216.8782.4140.8540.1440.070.045
Change In Working Capital -44.347-26.7593.003-5.588-1.626-4.327-2.752-0.872
Accounts Receivables -33.816-21.6780.84-0.218-3.166-2.5130.454-0.758
Inventory -28.092-8.024-4.894-1.74-4.121-2.699-2.497-1.587
Accounts Payables 6.957-3.275.09-5.8023.4430.164-0.7351.062
Other Working Capital 10.6046.2131.9672.1722.2180.7210.0260.411
Other Non Cash Items 29.9393.3741.3690.5110.4750.1770.0930.065
Operating Cash Flow -13.028-45.817-28.864-30.265-32.286-25.984-23.098-24.109
Investing Activities:
Investments In Property Plant And Equipment -179.059-11.907-3.519-0.455-0.165-0.418-0.263-1.478
Acquisitions Net -14.8940.107-32.78641.14360.336000
Purchases Of Investments 0-10.496-72.024-121.793-82.3710-19.187-46.534
Sales Maturities Of Investments 076.916104.8180.6522.03512.72544.3098.34
Other Investing Activites -27.212-0.10732.786-41.143-60.33612.72525.122-38.194
Investing Cash Flow -193.95354.51329.267-41.598-60.50112.30724.859-39.672
Financing Activities:
Debt Repayment -393.308-22.4590-2.2490-9.07600
Common Stock Issued 7.11145.4681.39375.54997.3670.0460.00363.629
Common Stock Repurchased 0.9550.5090.4190.3570000
Dividends Paid 00000000
Other Financing Activities -52.072145.4681.39375.549-4.64431.140.00363.544
Financing Cash Flow 400.418167.9271.39375.54992.72322.0640.00363.544
Other Information:
Effect Of Forex Changes On Cash 0.193-1.021-0.7970.803-0.085-0.0820.335-0.006
Net Change In Cash 193.63175.6020.9994.489-0.1498.3052.099-0.243
Cash At End Of Period 394.812201.68226.0825.08120.59220.74112.43610.337